AIMD
Price
$0.48
Change
+$0.04 (+9.09%)
Updated
Dec 18, 04:56 PM (EDT)
SINT
Price
$3.91
Change
+$0.84 (+27.36%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

AIMD vs SINT

Header iconAIMD vs SINT Comparison
Open Charts AIMD vs SINTBanner chart's image
Ainos
Price$0.48
Change+$0.04 (+9.09%)
Volume$100
CapitalizationN/A
SiNtx Technologies
Price$3.91
Change+$0.84 (+27.36%)
Volume$4.11K
CapitalizationN/A
AIMD vs SINT Comparison Chart
Loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIMD vs. SINT commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a Hold and SINT is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (AIMD: $0.44 vs. SINT: $3.07)
Brand notoriety: AIMD and SINT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AIMD: 9% vs. SINT: 65%
Market capitalization -- AIMD: $6.73M vs. SINT: $2.53M
AIMD [@Medical Specialties] is valued at $6.73M. SINT’s [@Medical Specialties] market capitalization is $2.53M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIMD’s FA Score shows that 0 FA rating(s) are green whileSINT’s FA Score has 1 green FA rating(s).

  • AIMD’s FA Score: 0 green, 5 red.
  • SINT’s FA Score: 1 green, 4 red.
According to our system of comparison, SINT is a better buy in the long-term than AIMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIMD’s TA Score shows that 3 TA indicator(s) are bullish while SINT’s TA Score has 3 bullish TA indicator(s).

  • AIMD’s TA Score: 3 bullish, 3 bearish.
  • SINT’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AIMD is a better buy in the short-term than SINT.

Price Growth

AIMD (@Medical Specialties) experienced а -0.86% price change this week, while SINT (@Medical Specialties) price change was -19.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.22%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +1.33%.

Reported Earning Dates

AIMD is expected to report earnings on Feb 28, 2024.

SINT is expected to report earnings on Mar 30, 2023.

Industries' Descriptions

@Medical Specialties (-4.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AIMD($6.73M) has a higher market cap than SINT($2.53M). AIMD YTD gains are higher at: -78.527 vs. SINT (-95.975). SINT (-8.4M) and AIMD (-8.75M) have comparable annual earnings (EBITDA) . SINT has more cash in the bank: 6.22M vs. AIMD (1.89M). SINT has less debt than AIMD: SINT (1.91M) vs AIMD (5.96M). SINT has higher revenues than AIMD: SINT (890K) vs AIMD (122K).
AIMDSINTAIMD / SINT
Capitalization6.73M2.53M266%
EBITDA-8.75M-8.4M104%
Gain YTD-78.527-95.97582%
P/E RatioN/A10.78-
Revenue122K890K14%
Total Cash1.89M6.22M30%
Total Debt5.96M1.91M312%
FUNDAMENTALS RATINGS
AIMD vs SINT: Fundamental Ratings
AIMD
SINT
OUTLOOK RATING
1..100
433
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
8860
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AIMD's Valuation (48) in the null industry is in the same range as SINT (58) in the Medical Specialties industry. This means that AIMD’s stock grew similarly to SINT’s over the last 12 months.

AIMD's Profit vs Risk Rating (100) in the null industry is in the same range as SINT (100) in the Medical Specialties industry. This means that AIMD’s stock grew similarly to SINT’s over the last 12 months.

AIMD's SMR Rating (97) in the null industry is in the same range as SINT (99) in the Medical Specialties industry. This means that AIMD’s stock grew similarly to SINT’s over the last 12 months.

SINT's Price Growth Rating (60) in the Medical Specialties industry is in the same range as AIMD (88) in the null industry. This means that SINT’s stock grew similarly to AIMD’s over the last 12 months.

SINT's P/E Growth Rating (4) in the Medical Specialties industry is significantly better than the same rating for AIMD (100) in the null industry. This means that SINT’s stock grew significantly faster than AIMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMDSINT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

AIMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, AIMD has been loosely correlated with AHICF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AIMD jumps, then AHICF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIMD
1D Price
Change %
AIMD100%
+2.32%
AHICF - AIMD
46%
Loosely correlated
N/A
BNR - AIMD
41%
Loosely correlated
+0.30%
SINT - AIMD
40%
Loosely correlated
+1.32%
APDN - AIMD
38%
Loosely correlated
+24.46%
COCH - AIMD
21%
Poorly correlated
+7.95%
More

SINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SINT has been closely correlated with BNR. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if SINT jumps, then BNR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SINT
1D Price
Change %
SINT100%
+1.32%
BNR - SINT
90%
Closely correlated
+0.30%
SSKN - SINT
85%
Closely correlated
+1.63%
APDN - SINT
84%
Closely correlated
+24.46%
GCTK - SINT
75%
Closely correlated
-3.77%
STSS - SINT
63%
Loosely correlated
-2.83%
More